Aviva PLC Invitae Corp Transaction History

Aviva PLC

  • $28.3 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$1.71 - $3.61 $1,321 - $2,790
773 Added 1.9%
41,423 $77,000
Q2 2022

Aug 04, 2022
BUY
$2.13 - $9.01 $29,939 - $126,644
14,056 Added 52.85%
40,650 $99,000
Q1 2022

May 13, 2022
BUY
$6.28 - $15.59 $31,111 - $77,232
4,954 Added 22.89%
26,594 $212,000
Q4 2021

Feb 10, 2022
BUY
$14.7 - $28.67 $318,108 - $620,418
21,640 New
21,640 $330,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email